{"transactions":[{"id":686987,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Performance Share Unit","published_at":"2026-08-14T21:10:26.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"shares":1650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1650},"source":{"system":"sec-edgar","filing":"0001804567-26-000014","document":"wk-form4_1786741823.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000014/wk-form4_1786741823.xml","form_type":"4"}},{"id":686986,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-08-14T21:10:26.000Z","date":"2026-08-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":797,"price":46.57,"value":37116.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":19544,"source":{"system":"sec-edgar","filing":"0001804567-26-000014","document":"wk-form4_1786741823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000014/wk-form4_1786741823.xml","form_type":"4"}},{"id":686985,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-08-14T21:10:26.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":1650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 251 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":20341,"source":{"system":"sec-edgar","filing":"0001804567-26-000014","document":"wk-form4_1786741823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000014/wk-form4_1786741823.xml","form_type":"4"}},{"id":700012,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Performance Share Unit","published_at":"2026-07-31T21:05:11.000Z","date":"2026-07-29","kind":"grant","planned":false,"acquired":true,"shares":1650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."}],"balance_after":1650,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1650},"source":{"system":"sec-edgar","filing":"0001804567-26-000012","document":"wk-form4_1785531908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000012/wk-form4_1785531908.xml","form_type":"4"}},{"id":851102,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Performance Share Unit","published_at":"2026-03-10T20:13:22.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001804567-26-000010","document":"wk-form4_1773173598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000010/wk-form4_1773173598.xml","form_type":"4"}},{"id":851101,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-03-10T20:13:22.000Z","date":"2026-03-09","kind":"sale","planned":false,"acquired":false,"shares":1623,"price":53.65,"value":87073.95,"ownership":{"direct":true},"balance_after":18440,"source":{"system":"sec-edgar","filing":"0001804567-26-000010","document":"wk-form4_1773173598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000010/wk-form4_1773173598.xml","form_type":"4"}},{"id":851100,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-03-10T20:13:22.000Z","date":"2026-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1793,"price":54.73,"value":98130.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":20063,"source":{"system":"sec-edgar","filing":"0001804567-26-000010","document":"wk-form4_1773173598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000010/wk-form4_1773173598.xml","form_type":"4"}},{"id":851099,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-03-10T20:13:22.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21856,"source":{"system":"sec-edgar","filing":"0001804567-26-000010","document":"wk-form4_1773173598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000010/wk-form4_1773173598.xml","form_type":"4"}},{"id":867783,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Performance Share Unit","published_at":"2026-03-03T21:09:51.000Z","date":"2026-02-28","kind":"grant","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."}],"balance_after":3750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001804567-26-000008","document":"wk-form4_1772572184.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000008/wk-form4_1772572184.xml","form_type":"4"}},{"id":879791,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-26T21:19:59.000Z","date":"2026-02-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."}],"balance_after":1875,"derivative":{"underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001804567-26-000006","document":"wk-form4_1772140796.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000006/wk-form4_1772140796.xml","form_type":"4"}},{"id":879790,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:19:59.000Z","date":"2026-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":977,"price":50.69,"value":49524.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":18106,"source":{"system":"sec-edgar","filing":"0001804567-26-000006","document":"wk-form4_1772140796.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000006/wk-form4_1772140796.xml","form_type":"4"}},{"id":879789,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:19:59.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19083,"source":{"system":"sec-edgar","filing":"0001804567-26-000006","document":"wk-form4_1772140796.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000006/wk-form4_1772140796.xml","form_type":"4"}},{"id":882097,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-25T21:54:37.000Z","date":"2026-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."}],"balance_after":2500,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001804567-26-000004","document":"wk-form4_1772056473.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000004/wk-form4_1772056473.xml","form_type":"4"}},{"id":882096,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-25T21:54:37.000Z","date":"2026-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001804567-26-000004","document":"wk-form4_1772056473.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000004/wk-form4_1772056473.xml","form_type":"4"}},{"id":882095,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-25T21:54:37.000Z","date":"2026-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026."}],"balance_after":3375,"derivative":{"underlying":"Common Stock","underlying_shares":1125},"source":{"system":"sec-edgar","filing":"0001804567-26-000004","document":"wk-form4_1772056473.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000004/wk-form4_1772056473.xml","form_type":"4"}},{"id":882094,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-02-25T21:54:37.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":670,"price":50.86,"value":34076.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":17208,"source":{"system":"sec-edgar","filing":"0001804567-26-000004","document":"wk-form4_1772056473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000004/wk-form4_1772056473.xml","form_type":"4"}},{"id":882093,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-02-25T21:54:37.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17878,"source":{"system":"sec-edgar","filing":"0001804567-26-000004","document":"wk-form4_1772056473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000004/wk-form4_1772056473.xml","form_type":"4"}},{"id":882092,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-02-25T21:54:37.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":368,"price":50.86,"value":18716.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":16628,"source":{"system":"sec-edgar","filing":"0001804567-26-000004","document":"wk-form4_1772056473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000004/wk-form4_1772056473.xml","form_type":"4"}},{"id":882091,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-02-25T21:54:37.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16996,"source":{"system":"sec-edgar","filing":"0001804567-26-000004","document":"wk-form4_1772056473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000004/wk-form4_1772056473.xml","form_type":"4"}},{"id":882090,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-02-25T21:54:37.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":603,"price":51.35,"value":30964.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":16246,"source":{"system":"sec-edgar","filing":"0001804567-26-000004","document":"wk-form4_1772056473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000004/wk-form4_1772056473.xml","form_type":"4"}},{"id":882089,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-02-25T21:54:37.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16849,"source":{"system":"sec-edgar","filing":"0001804567-26-000004","document":"wk-form4_1772056473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000004/wk-form4_1772056473.xml","form_type":"4"}},{"id":890774,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-20T21:46:49.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 18, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 18, 2027."}],"balance_after":3000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001804567-26-000002","document":"wk-form4_1771624006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000002/wk-form4_1771624006.xml","form_type":"4"}},{"id":890773,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-20T21:46:49.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal annual installments beginning on February 18, 2027."}],"balance_after":13500,"derivative":{"exercise_price":50.2,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001804567-26-000002","document":"wk-form4_1771624006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000002/wk-form4_1771624006.xml","form_type":"4"}},{"id":961060,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-22T21:04:25.000Z","date":"2025-12-19","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests in four equal annual installments beginning on February 24, 2018."}],"balance_after":0,"derivative":{"exercise_price":25.3,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001628280-25-058506","document":"wk-form4_1766437463.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025058506/wk-form4_1766437463.xml","form_type":"4"}},{"id":961059,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-22T21:04:25.000Z","date":"2025-12-19","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in four equal annual installments beginning on February 14, 2019 ."}],"balance_after":0,"derivative":{"exercise_price":39.4,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001628280-25-058506","document":"wk-form4_1766437463.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025058506/wk-form4_1766437463.xml","form_type":"4"}},{"id":961058,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2025-12-22T21:04:25.000Z","date":"2025-12-19","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":50.47,"value":757050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.69. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":15496,"source":{"system":"sec-edgar","filing":"0001628280-25-058506","document":"wk-form4_1766437463.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025058506/wk-form4_1766437463.xml","form_type":"4"}},{"id":961057,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2025-12-22T21:04:25.000Z","date":"2025-12-19","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":25.3,"value":379500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2025."}],"balance_after":30496,"source":{"system":"sec-edgar","filing":"0001628280-25-058506","document":"wk-form4_1766437463.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025058506/wk-form4_1766437463.xml","form_type":"4"}},{"id":961056,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2025-12-22T21:04:25.000Z","date":"2025-12-19","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":50.22,"value":251100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.39. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":15496,"source":{"system":"sec-edgar","filing":"0001628280-25-058506","document":"wk-form4_1766437463.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025058506/wk-form4_1766437463.xml","form_type":"4"}},{"id":961055,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2025-12-22T21:04:25.000Z","date":"2025-12-19","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":39.4,"value":197000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2025."}],"balance_after":20496,"source":{"system":"sec-edgar","filing":"0001628280-25-058506","document":"wk-form4_1766437463.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025058506/wk-form4_1766437463.xml","form_type":"4"}},{"id":1040563,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-09-15T21:39:00.000Z","date":"2025-09-12","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal annual installments beginning on February 14, 2019 ."}],"balance_after":5000,"derivative":{"exercise_price":39.4,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001804567-25-000006","document":"wk-form4_1757972337.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456725000006/wk-form4_1757972337.xml","form_type":"4"}},{"id":1040562,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2025-09-15T21:39:00.000Z","date":"2025-09-12","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":45.87,"value":229350.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.73 to $45.96. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":15496,"source":{"system":"sec-edgar","filing":"0001804567-25-000006","document":"wk-form4_1757972337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456725000006/wk-form4_1757972337.xml","form_type":"4"}},{"id":1040561,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2025-09-15T21:39:00.000Z","date":"2025-09-12","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":39.4,"value":197000.0,"ownership":{"direct":true},"balance_after":20496,"source":{"system":"sec-edgar","filing":"0001804567-25-000006","document":"wk-form4_1757972337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456725000006/wk-form4_1757972337.xml","form_type":"4"}},{"id":1054606,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-08-27T20:59:36.000Z","date":"2025-08-25","kind":"exercise","planned":false,"acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four equal annual installments beginning on March 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":12.98,"expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001804567-25-000004","document":"wk-form4_1756328373.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456725000004/wk-form4_1756328373.xml","form_type":"4"}},{"id":1054605,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2025-08-27T20:59:36.000Z","date":"2025-08-25","kind":"sale","planned":false,"acquired":false,"shares":14000,"price":44.51,"value":623140.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person exercised the options indicated herein and sold the underlying shares prior to the expiration of such options on March 1, 2026."}],"balance_after":15496,"source":{"system":"sec-edgar","filing":"0001804567-25-000004","document":"wk-form4_1756328373.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456725000004/wk-form4_1756328373.xml","form_type":"4"}},{"id":1054604,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2025-08-27T20:59:36.000Z","date":"2025-08-25","kind":"exercise","planned":false,"acquired":true,"shares":14000,"price":12.98,"value":181720.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 345 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":29496,"source":{"system":"sec-edgar","filing":"0001804567-25-000004","document":"wk-form4_1756328373.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456725000004/wk-form4_1756328373.xml","form_type":"4"}},{"id":1217530,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Performance Share Units","published_at":"2025-03-07T21:34:07.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":false,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2625},"source":{"system":"sec-edgar","filing":"0001628280-25-011325","document":"wk-form4_1741383241.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025011325/wk-form4_1741383241.xml","form_type":"4"}},{"id":1217529,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2025-03-07T21:34:07.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":1356,"price":39.11,"value":53033.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":15151,"source":{"system":"sec-edgar","filing":"0001628280-25-011325","document":"wk-form4_1741383241.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025011325/wk-form4_1741383241.xml","form_type":"4"}},{"id":1217528,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2025-03-07T21:34:07.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":true,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 17, 2025."}],"balance_after":16507,"source":{"system":"sec-edgar","filing":"0001628280-25-011325","document":"wk-form4_1741383241.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025011325/wk-form4_1741383241.xml","form_type":"4"}},{"id":1222730,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2025-03-05T21:19:15.000Z","date":"2025-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":945,"price":33.05,"value":31232.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Restricted Stock Units."}],"balance_after":13882,"source":{"system":"sec-edgar","filing":"0001628280-25-010472","document":"wk-form4_1741209547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025010472/wk-form4_1741209547.xml","form_type":"4"}},{"id":1222729,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2025-03-05T21:19:15.000Z","date":"2025-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":610,"price":33.05,"value":20160.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Restricted Stock Units."}],"balance_after":14827,"source":{"system":"sec-edgar","filing":"0001628280-25-010472","document":"wk-form4_1741209547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025010472/wk-form4_1741209547.xml","form_type":"4"}},{"id":1222728,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2025-03-05T21:19:15.000Z","date":"2025-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":337,"price":33.05,"value":11137.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Restricted Stock Units."}],"balance_after":15437,"source":{"system":"sec-edgar","filing":"0001628280-25-010472","document":"wk-form4_1741209547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025010472/wk-form4_1741209547.xml","form_type":"4"}},{"id":1243430,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Performance Share Units","published_at":"2025-02-26T22:56:45.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001628280-25-008262","document":"wk-form4_1740610595.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025008262/wk-form4_1740610595.xml","form_type":"4"}},{"id":1243429,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Performance Share Units","published_at":"2025-02-26T22:56:45.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":false,"shares":2010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2022, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2022, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2010},"source":{"system":"sec-edgar","filing":"0001628280-25-008262","document":"wk-form4_1740610595.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025008262/wk-form4_1740610595.xml","form_type":"4"}},{"id":1243428,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2025-02-26T22:56:45.000Z","date":"2025-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1909,"price":39.48,"value":75367.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":15774,"source":{"system":"sec-edgar","filing":"0001628280-25-008262","document":"wk-form4_1740610595.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025008262/wk-form4_1740610595.xml","form_type":"4"}},{"id":1243427,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2025-02-26T22:56:45.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17683,"source":{"system":"sec-edgar","filing":"0001628280-25-008262","document":"wk-form4_1740610595.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025008262/wk-form4_1740610595.xml","form_type":"4"}},{"id":1243426,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2025-02-26T22:56:45.000Z","date":"2025-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":976,"price":39.48,"value":38532.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":13933,"source":{"system":"sec-edgar","filing":"0001628280-25-008262","document":"wk-form4_1740610595.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025008262/wk-form4_1740610595.xml","form_type":"4"}},{"id":1243425,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2025-02-26T22:56:45.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":true,"shares":2010,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14909,"source":{"system":"sec-edgar","filing":"0001628280-25-008262","document":"wk-form4_1740610595.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025008262/wk-form4_1740610595.xml","form_type":"4"}},{"id":1249772,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Restricted Stock Unit","published_at":"2025-02-25T01:18:34.000Z","date":"2025-02-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."}],"balance_after":3750,"derivative":{"underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001628280-25-007528","document":"wk-form4_1740446308.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025007528/wk-form4_1740446308.xml","form_type":"4"}},{"id":1249771,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Restricted Stock Unit","published_at":"2025-02-25T01:18:34.000Z","date":"2025-02-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."}],"balance_after":3750,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001628280-25-007528","document":"wk-form4_1740446308.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025007528/wk-form4_1740446308.xml","form_type":"4"}},{"id":1249770,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Restricted Stock Unit","published_at":"2025-02-25T01:18:34.000Z","date":"2025-02-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."}],"balance_after":750,"derivative":{"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001628280-25-007528","document":"wk-form4_1740446308.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025007528/wk-form4_1740446308.xml","form_type":"4"}},{"id":1249769,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Performance Share Units","published_at":"2025-02-25T01:18:34.000Z","date":"2025-02-21","kind":"exercise","planned":false,"acquired":false,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1125},"source":{"system":"sec-edgar","filing":"0001628280-25-007528","document":"wk-form4_1740446308.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025007528/wk-form4_1740446308.xml","form_type":"4"}},{"id":1249768,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2025-02-25T01:18:34.000Z","date":"2025-02-23","kind":"grant","planned":false,"acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12899,"source":{"system":"sec-edgar","filing":"0001628280-25-007528","document":"wk-form4_1740446308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025007528/wk-form4_1740446308.xml","form_type":"4"}},{"id":1249767,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2025-02-25T01:18:34.000Z","date":"2025-02-22","kind":"grant","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11024,"source":{"system":"sec-edgar","filing":"0001628280-25-007528","document":"wk-form4_1740446308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025007528/wk-form4_1740446308.xml","form_type":"4"}},{"id":1249766,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2025-02-25T01:18:34.000Z","date":"2025-02-22","kind":"grant","planned":false,"acquired":true,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9774,"source":{"system":"sec-edgar","filing":"0001628280-25-007528","document":"wk-form4_1740446308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025007528/wk-form4_1740446308.xml","form_type":"4"}},{"id":1249765,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2025-02-25T01:18:34.000Z","date":"2025-02-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":552,"price":39.15,"value":21610.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":9024,"source":{"system":"sec-edgar","filing":"0001628280-25-007528","document":"wk-form4_1740446308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025007528/wk-form4_1740446308.xml","form_type":"4"}},{"id":1249764,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2025-02-25T01:18:34.000Z","date":"2025-02-21","kind":"exercise","planned":false,"acquired":true,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 21, 2025."}],"balance_after":9576,"source":{"system":"sec-edgar","filing":"0001628280-25-007528","document":"wk-form4_1740446308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025007528/wk-form4_1740446308.xml","form_type":"4"}},{"id":1253082,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Restricted Stock Unit","published_at":"2025-02-21T21:57:47.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026."}],"balance_after":4500,"derivative":{"underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001628280-25-007194","document":"wk-form4_1740175057.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025007194/wk-form4_1740175057.xml","form_type":"4"}},{"id":1253081,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-21T21:57:47.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal annual installments beginning on February 19, 2026."}],"balance_after":20000,"derivative":{"exercise_price":33.52,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001628280-25-007194","document":"wk-form4_1740175057.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025007194/wk-form4_1740175057.xml","form_type":"4"}},{"id":1260248,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Performance Share Units","published_at":"2025-02-19T21:35:15.000Z","date":"2025-02-17","kind":"grant","planned":false,"acquired":true,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":2625,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2625},"source":{"system":"sec-edgar","filing":"0001628280-25-006401","document":"wk-form4_1740000906.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025006401/wk-form4_1740000906.xml","form_type":"4"}},{"id":1280359,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Performance Share Units","published_at":"2025-02-06T21:57:05.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":2010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2022, the Reporting Person was awarded Performance Share Units, portions of which vested upon the achievement of individual performance objectives within defined performance\nperiods, which objectives were established on May 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2022, the Reporting Person was awarded Performance Share Units, portions of which vested upon the achievement of individual performance objectives within defined performance\nperiods, which objectives were established on May 3, 2022."}],"balance_after":2010,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2010},"source":{"system":"sec-edgar","filing":"0001628280-25-004278","document":"wk-form4_1738879018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025004278/wk-form4_1738879018.xml","form_type":"4"}},{"id":1280358,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Performance Share Units","published_at":"2025-02-06T21:57:05.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":3750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001628280-25-004278","document":"wk-form4_1738879018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025004278/wk-form4_1738879018.xml","form_type":"4"}},{"id":1291916,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Performance Share Units","published_at":"2025-01-29T21:59:11.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":1125,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1125},"source":{"system":"sec-edgar","filing":"0001628280-25-003012","document":"wk-form4_1738187944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828025003012/wk-form4_1738187944.xml","form_type":"4"}},{"id":1371498,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-11-08T21:13:57.000Z","date":"2024-11-07","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested in four equal installments beginning on March 3, 2016."}],"balance_after":0,"derivative":{"exercise_price":9.13,"exercise_date":"2016-03-03","expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001628280-24-046668","document":"wk-form4_1731100428.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828024046668/wk-form4_1731100428.xml","form_type":"4"}},{"id":1371497,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2024-11-08T21:13:57.000Z","date":"2024-11-07","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":36.98,"value":554700.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person exercised the options indicated herein and sold the underlying shares prior to the expiration of such options on March 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.73 to $37.27. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":8200,"source":{"system":"sec-edgar","filing":"0001628280-24-046668","document":"wk-form4_1731100428.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828024046668/wk-form4_1731100428.xml","form_type":"4"}},{"id":1371496,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2024-11-08T21:13:57.000Z","date":"2024-11-07","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":9.13,"value":136950.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 421 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":23200,"source":{"system":"sec-edgar","filing":"0001628280-24-046668","document":"wk-form4_1731100428.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000162828024046668/wk-form4_1731100428.xml","form_type":"4"}},{"id":1610128,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Performance Share Unit","published_at":"2024-02-29T22:01:46.000Z","date":"2024-02-28","kind":"exercise","planned":false,"acquired":false,"shares":990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":990},"source":{"system":"sec-edgar","filing":"0001104659-24-029434","document":"tm247055-37_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465924029434/tm247055-37_4seq1.xml","form_type":"4"}},{"id":1610127,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2024-02-29T22:01:46.000Z","date":"2024-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":460,"price":27.94,"value":12852.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":7779,"source":{"system":"sec-edgar","filing":"0001104659-24-029434","document":"tm247055-37_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465924029434/tm247055-37_4seq1.xml","form_type":"4"}},{"id":1610126,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2024-02-29T22:01:46.000Z","date":"2024-02-28","kind":"exercise","planned":false,"acquired":true,"shares":990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2022."}],"balance_after":8239,"source":{"system":"sec-edgar","filing":"0001104659-24-029434","document":"tm247055-37_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465924029434/tm247055-37_4seq1.xml","form_type":"4"}},{"id":1616084,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Restricted Stock Unit","published_at":"2024-02-27T22:02:19.000Z","date":"2024-02-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."}],"balance_after":5625,"derivative":{"underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001104659-24-028276","document":"tm247055-20_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465924028276/tm247055-20_4seq1.xml","form_type":"4"}},{"id":1616083,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2024-02-27T22:02:19.000Z","date":"2024-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":937,"price":29.06,"value":27229.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":7249,"source":{"system":"sec-edgar","filing":"0001104659-24-028276","document":"tm247055-20_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465924028276/tm247055-20_4seq1.xml","form_type":"4"}},{"id":1616082,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2024-02-27T22:02:19.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8186,"source":{"system":"sec-edgar","filing":"0001104659-24-028276","document":"tm247055-20_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465924028276/tm247055-20_4seq1.xml","form_type":"4"}},{"id":1619714,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Performance Share Unit","published_at":"2024-02-26T22:00:55.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022."}],"balance_after":990,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":990},"source":{"system":"sec-edgar","filing":"0001104659-24-027571","document":"tm247055-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465924027571/tm247055-4_4seq1.xml","form_type":"4"}},{"id":1619713,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-26T22:00:55.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in four equal annual installments beginning on February 22, 2025."}],"balance_after":25000,"derivative":{"exercise_price":27.94,"expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-24-027571","document":"tm247055-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465924027571/tm247055-4_4seq1.xml","form_type":"4"}},{"id":1619712,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Restricted Stock Unit","published_at":"2024-02-26T22:00:55.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-24-027571","document":"tm247055-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465924027571/tm247055-4_4seq1.xml","form_type":"4"}},{"id":1619711,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Restricted Stock Unit","published_at":"2024-02-26T22:00:55.000Z","date":"2024-02-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."}],"balance_after":1500,"derivative":{"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001104659-24-027571","document":"tm247055-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465924027571/tm247055-4_4seq1.xml","form_type":"4"}},{"id":1619710,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2024-02-26T22:00:55.000Z","date":"2024-02-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":335,"price":27.94,"value":9359.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":6311,"source":{"system":"sec-edgar","filing":"0001104659-24-027571","document":"tm247055-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465924027571/tm247055-4_4seq1.xml","form_type":"4"}},{"id":1619709,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2024-02-26T22:00:55.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 215 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":6646,"source":{"system":"sec-edgar","filing":"0001104659-24-027571","document":"tm247055-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465924027571/tm247055-4_4seq1.xml","form_type":"4"}},{"id":1739199,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-11-16T22:00:06.000Z","date":"2023-11-14","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in four equal annual installments beginning on January 21, 2015."}],"balance_after":0,"derivative":{"exercise_price":9.24,"expiration_date":"2024-01-21","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001104659-23-119162","document":"tm2330879-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465923119162/tm2330879-1_4seq1.xml","form_type":"4"}},{"id":1739198,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2023-11-16T22:00:06.000Z","date":"2023-11-14","kind":"sale","planned":false,"acquired":false,"shares":1110,"price":28.13,"value":31224.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock sold to cover the exercise price of the employee stock options."}],"balance_after":5681,"source":{"system":"sec-edgar","filing":"0001104659-23-119162","document":"tm2330879-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465923119162/tm2330879-1_4seq1.xml","form_type":"4"}},{"id":1739197,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2023-11-16T22:00:06.000Z","date":"2023-11-14","kind":"exercise","planned":false,"acquired":true,"shares":2000,"price":9.24,"value":18480.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 343 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":6791,"source":{"system":"sec-edgar","filing":"0001104659-23-119162","document":"tm2330879-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465923119162/tm2330879-1_4seq1.xml","form_type":"4"}},{"id":1921036,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, Quality, GMP Oper. & IT"}}],"security":"Restricted Stock Units","published_at":"2023-04-12T21:00:49.000Z","date":"2023-02-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023."}],"balance_after":2250,"derivative":{"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001104659-23-044665","document":"tm2312277-3_4aseq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465923044665/tm2312277-3_4aseq.xml","form_type":"4/A","original_submission_date":"2023-02-24"}},{"id":1921035,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, Quality, GMP Oper. & IT"}}],"security":"Common Stock","published_at":"2023-04-12T21:00:49.000Z","date":"2023-02-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":289,"price":38.57,"value":11146.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":9228,"source":{"system":"sec-edgar","filing":"0001104659-23-044665","document":"tm2312277-3_4aseq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465923044665/tm2312277-3_4aseq.xml","form_type":"4/A","original_submission_date":"2023-02-24"}},{"id":1921034,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, Quality, GMP Oper. & IT"}}],"security":"Common Stock","published_at":"2023-04-12T21:00:49.000Z","date":"2023-02-22","kind":"grant","planned":false,"acquired":true,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 576 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":9517,"source":{"system":"sec-edgar","filing":"0001104659-23-044665","document":"tm2312277-3_4aseq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465923044665/tm2312277-3_4aseq.xml","form_type":"4/A","original_submission_date":"2023-02-24"}},{"id":1950143,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, Quality, GMP Oper. & IT"}}],"security":"Common Stock","published_at":"2023-03-16T21:00:55.000Z","date":"2023-03-14","kind":"sale","acquired":false,"shares":4780,"price":35.988,"value":172022.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.96 to $36.02. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":4737,"source":{"system":"sec-edgar","filing":"0001104659-23-033366","document":"tm239705-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465923033366/tm239705-1_4seq1.xml","form_type":"4"}},{"id":1990554,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Restricted Stock Units","published_at":"2023-02-27T22:00:46.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 23, 2024."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-23-026071","document":"tm237737-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465923026071/tm237737-11_4seq1.xml","form_type":"4"}},{"id":1990553,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-02-27T22:00:46.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on February 23, 2024."}],"balance_after":30000,"derivative":{"exercise_price":38.6,"expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-23-026071","document":"tm237737-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465923026071/tm237737-11_4seq1.xml","form_type":"4"}},{"id":1993452,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Restricted Stock Units","published_at":"2023-02-24T22:01:22.000Z","date":"2023-02-22","kind":"disposition_to_issuer","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023."}],"balance_after":2250,"derivative":{"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001104659-23-025368","document":"tm237737-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465923025368/tm237737-7_4seq1.xml","form_type":"4"}},{"id":1993451,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2023-02-24T22:01:22.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 576 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":9517,"source":{"system":"sec-edgar","filing":"0001104659-23-025368","document":"tm237737-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465923025368/tm237737-7_4seq1.xml","form_type":"4"}},{"id":2003735,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Performance Share Unit","published_at":"2023-02-21T22:35:38.000Z","date":"2023-02-16","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On April 30 2021, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001104659-23-023877","document":"tm237193-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465923023877/tm237193-1_4seq1.xml","form_type":"4"}},{"id":2003734,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2023-02-21T22:35:38.000Z","date":"2023-02-16","kind":"tax_withholding","acquired":false,"shares":753,"price":38.74,"value":29171.22,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on April 30, 2021."}],"balance_after":8191,"source":{"system":"sec-edgar","filing":"0001104659-23-023877","document":"tm237193-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465923023877/tm237193-1_4seq1.xml","form_type":"4"}},{"id":2003733,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Common Stock","published_at":"2023-02-21T22:35:38.000Z","date":"2023-02-16","kind":"exercise","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on April 30, 2021."}],"balance_after":8944,"source":{"system":"sec-edgar","filing":"0001104659-23-023877","document":"tm237193-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465923023877/tm237193-1_4seq1.xml","form_type":"4"}},{"id":2053808,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Performance Share Unit","published_at":"2023-01-17T22:03:16.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 30 2021, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period."}],"balance_after":1500,"derivative":{"exercise_price":0,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001104659-23-004292","document":"tm233672-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465923004292/tm233672-3_4seq1.xml","form_type":"4"}},{"id":2372292,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Restricted Stock Units","published_at":"2022-02-25T22:15:50.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The option vests in four equal annual installments beginning on February 22, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person is amending Form 4 filed on February 24, 2022 to reflect that these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023, rather than such vesting occurring entirely on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person is amending Form 4 filed on February 24, 2022 to reflect that these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023, rather than such vesting occurring entirely on February 22, 2023."}],"balance_after":3000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001104659-22-027394","document":"tm227764-3_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465922027394/tm227764-3_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-02-24"}},{"id":2372291,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-25T22:15:50.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."}],"balance_after":18000,"derivative":{"exercise_price":32.2,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-22-027394","document":"tm227764-3_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465922027394/tm227764-3_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-02-24"}},{"id":2374977,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Restricted Stock Units","published_at":"2022-02-25T02:26:13.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023."}],"balance_after":3000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001104659-22-026881","document":"tm227622-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465922026881/tm227622-9_4seq1.xml","form_type":"4"}},{"id":2374976,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP, Ops, IT"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-25T02:26:13.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal annual installments beginning on February 22, 2023."}],"balance_after":18000,"derivative":{"exercise_price":32.2,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-22-026881","document":"tm227622-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465922026881/tm227622-9_4seq1.xml","form_type":"4"}},{"id":2839701,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Quality, GMP Ops. & IT"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-23T23:53:14.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal annual installments beginning on February 19, 2022."}],"balance_after":17000,"derivative":{"exercise_price":29.61,"expiration_date":"2031-02-19","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-21-026935","document":"tm217706-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465921026935/tm217706-8_4seq1.xml","form_type":"4"}},{"id":3249707,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, Quality, GMP Oper. & IT"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-02-25T23:51:15.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on February 21, 2021."}],"balance_after":22000,"derivative":{"exercise_price":23.99,"expiration_date":"2030-02-21","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001104659-20-024920","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000110465920024920/a4.xml","form_type":"4"}}]}